On September 9, 2020, Katherine Eban, New York Times bestselling author of Bottle of Lies, and Joe Graedon, founder and host of The People’s Pharmacy, joined Valisure Co-Founder & President David Light for a critical conversation on the state of the U.S. drug supply.
The discussion—“The Battle for Generic Drug Quality”—explored how fraud, limited regulatory oversight, and overseas manufacturing practices have compromised the safety and effectiveness of generic medications, putting American consumers at risk.
Together, the panelists emphasized the urgent need for independent testing, greater transparency, and accountability in pharmaceutical manufacturing to restore confidence in the drug supply chain.
On September 9, 2020, Katherine Eban, New York Times bestselling author of Bottle of Lies, and Joe Graedon, founder and host of The People’s Pharmacy, joined Valisure Co-Founder & President David Light for a critical conversation on the state of the U.S. drug supply.
The discussion—“The Battle for Generic Drug Quality”—explored how fraud, limited regulatory oversight, and overseas manufacturing practices have compromised the safety and effectiveness of generic medications, putting American consumers at risk.
Together, the panelists emphasized the urgent need for independent testing, greater transparency, and accountability in pharmaceutical manufacturing to restore confidence in the drug supply chain.
On September 9, 2020, Katherine Eban, New York Times bestselling author of Bottle of Lies, and Joe Graedon, founder and host of The People’s Pharmacy, joined Valisure Co-Founder & President David Light for a critical conversation on the state of the U.S. drug supply.
The discussion—“The Battle for Generic Drug Quality”—explored how fraud, limited regulatory oversight, and overseas manufacturing practices have compromised the safety and effectiveness of generic medications, putting American consumers at risk.
Together, the panelists emphasized the urgent need for independent testing, greater transparency, and accountability in pharmaceutical manufacturing to restore confidence in the drug supply chain.
On September 9, 2020, Katherine Eban, New York Times bestselling author of Bottle of Lies, and Joe Graedon, founder and host of The People’s Pharmacy, joined Valisure Co-Founder & President David Light for a critical conversation on the state of the U.S. drug supply.
The discussion—“The Battle for Generic Drug Quality”—explored how fraud, limited regulatory oversight, and overseas manufacturing practices have compromised the safety and effectiveness of generic medications, putting American consumers at risk.
Together, the panelists emphasized the urgent need for independent testing, greater transparency, and accountability in pharmaceutical manufacturing to restore confidence in the drug supply chain.